Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synbiotic in Hepatitis B Cirrhosis
NCT05687409Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands, Live Biotherapeutic Products, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of lactulose, clostridium butyricum, Bifidobacterium longum subsp. infantis in Liver cirrhosis (LC), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Started Nov 2019; status: completed.
02
Drugs
lactuloseclostridium butyricumBifidobacterium longum subsp. infantis
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05687409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687409.